Page 166 - Materials Chemistry, Second Edition
P. 166

L1644_C04.fm  Page 138  Tuesday, October 21, 2003  3:13 PM










                                 TABLE 4.3
                                 Example of RfD Values and Potential Factors
                                               RfD         Oral cancer factor   Inhalation cancer
                                             (mg/day/kg)     (kg/day/mg)     factor (kg/day/mg)
                                   As         3.0 × 10 –4       1.75               50
                                   Cd         5.0 × 10 –4        —                 6.3
                                   Cr           1.0              —                 42
                                   Ni         2.0 × 10 –2        —                1.19
                                   Pb         6.0 × 10 –3        —                 —
                                   Hg         3.0 × 10 –4        —                 —
                                   Sn         6.0 × 10 –1        —                 —
                                   Zn         3.0 × 10 –1        —                 —
                                 PCDD/Fs      4.0 × 10 –9     1.56 × 10 5       1.16 × 10 5
                                 Source: IRIS (1996), EPA Integrated Risk Information System,  available online at:
                                 http://www.epa.gov/ngispgm3/iris/.


                             The RfD has the unit milligram of a daily intake of the toxic element, which is absorbed
                             in the body, divided by body weight (Table 4.3) (Olsen et al., 2000).
                                Baird et al. (1996) analyzed the RfDs reported in the USEPA’s Integrated Risk
                             Information System database (IRIS, 1996). Of 231 RfDs evaluated, 56% were below
                             the 5th percentile in corresponding uncertainty distributions, 44% were between the
                             5th and 15th percentiles and 3% were above the 15th percentile. Such a conserva-
                             tively biased approach is consistent with the objectives of many risk-screening
                             assessments (Krewitt et al., 2002).
                                In carcinogenic and noncarcinogenic effects, it can be expected that some of the
                             available data for existing substances have been derived from studies conducted in
                             vitro — the basic (and perhaps additional) studies on genotoxicity, for example. In
                             vitro  studies may yield data on, for instance, metabolism and/or mechanism of
                             actions (including studies in cell cultures from different species), dermal absorption
                             (which may also be for different species) and various aspects of toxicity (e.g., test
                             for  cytotoxicity in different types of cells, macromolecule bonding studies, tests
                             using embryo culture systems, and sperm mobility tests).

                             4.6.1.3  Epidemiological Information

                             Some data can be obtained from clinical studies of humans who have inadvertently
                             been exposed to a suspected toxicant; thus, a source of information relating exposure
                             to risk is obtained from epidemiological studies. Epidemiology is the study of the
                             incidence rate of diseases in real populations. When attempting to find correlations
                             between elevated rates of incidence of a particular disease in certain groups of people
                             and some measure of their exposure to various environmental factors, an epidemi-
                             ologist tries to show in a quantitative way the relationship between exposure and
                             risk. Such data should be used to complement animal data, clinical data and scientific
                             analyses of the characteristics of the substances in question.


                             © 2004 CRC Press LLC
   161   162   163   164   165   166   167   168   169   170   171